Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANDI-POAF
2024-518950-17-00Phase 3Authorised
- Sponsor
- Medical University of Vienna
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and arrhythmia comparing Landiolol hydrochloride arm with Placebo arm (2 arms). Planned start Jan 2025; status: authorised.
02
Drugs
landiolol
03
Conditions
Atrial fibrillation (AFib)arrhythmia
Beyond the preview
Go deeper on 2024-518950-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518950-17-00.